Fig. 2From: Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant dataForest plot of a the overall survival (OS) and b progression-free survival (PFS) by trialBack to article page